So-Young International reports Q4 results (NASDAQ:SY)

So-Young International press release (NASDAQ:SY): Q4 EPADS OF $0.03 Total revenues were RMB390.6 million (US$55.0 million), compared with RMB325.1 million in the corresponding period of 2022, in line with previous guidance. Information services and other revenues were RMB268.1 million (US$37.8 million), an increase of 15.8% from RMB231.5 million in the same period of 2022. The increase was primarily due to an increase in revenues generated by So-Young Prime. Reservation services revenues were RMB20.6 million (US$2.9 million), a decrease of 20.7% from RMB26.0 million in the same period of 2022. The decrease was primarily due to the operating strategy which gave higher subsidies to end users. Sales of medical products and maintenance services revenues were RMB101.9 million (US$14.4 million), an increase of 50.6% from RMB67.7 million in the same period of 2022, primarily due to an increase in sales of cosmetic injectables. Average mobile MAUs were 2.7 million, compared with 4.0 million in the fourth quarter of 2022. Number of medical service providers subscribing to information services on So-Young’s platform was 1,289, compared with 1,489 in the fourth quarter of 2022. Total number of purchasing users through reservation services was 139.0 thousand and the aggregate value of medical aesthetic treatment transactions facilitated by So-Young’s platform was RMB470.9 million.